Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Prognostic value of circulating tumor DNA in operable non-small cell lung cancer: a systematic review and reconstructed individual patient-data based meta-analysis

Fig. 4

Synthesis of individual patient data (IPD)-based disease-free survival (DFS) by combined analysis of two parameters. A DFS by ctDNA status change from baseline to postoperative timepoints. B DFS by ctDNA status change before and after ACT. C DFS by postoperative ctDNA status and whether adjuvant chemotherapy (ACT) was conducted or not. D DFS by postoperative ctDNA status and whether ACT was conducted or not for patients at stage II&III

Back to article page